InvestorsHub Logo
Followers 19
Posts 1222
Boards Moderated 0
Alias Born 04/03/2020

Re: Scooter McCabe post# 197853

Thursday, 12/23/2021 10:42:20 AM

Thursday, December 23, 2021 10:42:20 AM

Post# of 233039
With "If" being the key word.

Couple of relevant links for everyone:

https://www.nsf.org/locations/north-america/amarex-clinical-research-llc

and

https://www.fiercebiotech.com/cro/nsf-international-buys-up-cro-amarex

and

https://www.amarexcro.com/news/investment-nsf-international-amarex

Amarex will be a part of NSF International’s global health science consulting business, and will be referred to as Amarex Clinical Research, LLC, an NSF International company. Amarex founder Dr. Kazem Kazempour, will continue as President and CEO of Amarex under NSF International.



Please explain how "Health organization NSF International is delving deeper into life sciences after buying up the majority stake of CRO Amarex Clinical Research.", meshes with NSF saying there is no jurisdiction. You can't have it both ways.

They either own a majority stake in Amarex, or they don't. Again, can't have it both ways. What NSF is claiming doesn't match the record, which includes emails directly in conflict with the claims being made in their court filing.


The greatest enemy of knowledge is not ignorance; it is the illusion of knowledge.
- Stephen Hawking

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News